好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Diagnostic Impact of a Device-enabled Remote “Tele-Dizzy” Consultation Service
Neuro-ophthalmology/Neuro-otology
S32 - Neuro-ophthalmology/Neuro-otology (5:18 PM-5:30 PM)
010

Last year, we described a video-oculography-based remote Tele-Dizzy (TD) consultation service to improve diagnosis of acute vertigo in the ED. This year, we describe the results of this intervention.

Missed stroke in the ED is a leading cause of misdiagnosis-related harms. Diagnostic errors in acute dizziness/vertigo are frequent for both vestibular disorders (~80% misdiagnosed) and stroke (~35% missed).

This is a case study of a hospital-level quality improvement intervention. We deployed an ED TD consultation service to improve diagnosis of vertigo.

Since July 1, 2017, we have performed 231 consults at Johns Hopkins Hospital (JHH). We have seen improvements in diagnostic accuracy and reductions in unnecessary test utilization.

Accuracy: Without TD, the non-specific R42 “dizziness” ICD10 code diagnosis was made in 40% of all patients with dizziness/vertigo in 2015. Among those receiving a TD consultation, only 16.8% (n=39/231) were given a non-specific code - i.e., the number of symptom-only non-diagnoses was cut in half. 55% were given specific vestibular diagnoses (n=128/231) compared to a base rate of 8%.

Utilization: Without TD, the JH CT rate for all patients with vertigo in 2015 was 39%. With TD, only 2.2% (n=5/231) were recommended to receive a CT scan - i.e., reduction in CT rate of >90%. Without TD, the JH MRI rate for patients with dizziness or vertigo in 2015 was 20%. With TD, 19% (n=44/231) were recommended to receive a MRI - i.e., the rate of CTs was not reduced by simply ordering more MRI’s.

Our TD service has provided greater diagnostic accuracy and, simultaneously, lower utilization for patients who undergo consultation. Those who undergo neuroimaging receive the correct test (MRI), rather than an incorrect one (CT). Our next steps will be to expand our services to two community hospitals and test the hypothesis of lower risks of missed stroke, using a larger sample.

Authors/Disclosures
David S. Zee, MD (Johns Hopkins Hospital)
PRESENTER
Dr. Zee has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for florida legal. Dr. Zee has received publishing royalties from a publication relating to health care. Dr. Zee has received personal compensation in the range of $500-$4,999 for serving as a lectuer with u of pittsburg physical therapy. Dr. Zee has received personal compensation in the range of $500-$4,999 for serving as a lecturer with johms hopkins CME.
David E. Newman-Toker, MD, PhD, FAAN (Johns Hopkins Unversity School of Medicine, Dept of Neurology) The institution of Dr. Newman-Toker has received research support from NIH, AHRQ, AHA, Moore Foundation. Dr. Newman-Toker has received intellectual property interests from a discovery or technology relating to health care.
Roksolyana R. Tourkevich, MD (Center for Neurosciences) No disclosure on file
Anthony J. Brune III, DO (Memorial Healthcare Institute for Neuroscience) Dr. Brune has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Pharmaceuticals.
Kemar E. Green, DO (John's Hopkins Medicine) Dr. Green has nothing to disclose.
No disclosure on file
Mehdi Fanai, MD No disclosure on file
No disclosure on file
Daniel R. Gold, DO (Johns Hopkins) Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer . Dr. Gold has received publishing royalties from a publication relating to health care.